Charlie is a senior counsel in our Cambridge office specialising in the commercialisation of intellectual property in the life sciences and technology sectors.
Charlie specialises in the commercialisation of intellectual property in the life sciences and technology sectors. He works with clients on key strategic transactions throughout their lifecycle. This ranges from advising start-ups on foundational licensing deals and R&D collaborations through to working with established multinational companies on distribution, manufacturing and other commercial arrangements. He also advises on the IP, commercial and regulatory aspects of VC investment and M&A.
With over a decade of experience in the Cambridge ecosystem, Charlie has a particular focus on leveraging his later-stage experience when advising early-stage clients and regularly delivers training to new founders taking part in life sciences incubators and accelerators throughout the UK.
Leading associate
Corporate and commercial - Cambridge
Intellectual Property
作者 Colin McCall 以及 Charlie Adams
Licensing the Cabilly antibody manufacturing patents: are royalties payable on post-expiry sales?
作者
作者